
Vol. 113, No. 2, 2005
Free Abstract
Article (Fulltext)
Article (PDF 50 KB)
Case Report
CD20-Negative Pyothorax-Associated B Cell Lymphoma
Kenji Fukunoa,c, Hisashi Tsurumic, Nobuhiro Kanemuraa, Masaru Nishioa, Shinobu Tanabashia, Kiyonao Okamotob, Hisataka Moriwakic
Departments of aInternal Medicine and bPathology, Takayama Red Cross Hospital, Takayama, cFirst Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan
Address of Corresponding Author
Acta Haematol 2005;113:144-145 (DOI: 10.1159/000083453)
Key Words
- CD20
- Epstein-Barr virus
- Pyothorax-associated lymphoma
- THP-COP therapy
- Tuberculous pleuritis
Abstract
We describe an 86-year-old male who developed CD20-negative pyothorax-associated B cell lymphoma 64 years after he had suffered from tuberculous pleuritis. Therapy with 8 courses of THP-COP at 2-week intervals was followed by involved-field radiotherapy of 30 Gy. Uncertain complete remission was achieved. Thereafter, local recurrence of pyothorax-associated lymphoma (PAL) at the primary site was seen. The patient received salvage radiotherapy of 50 Gy. The patient died of pneumonia during a second uncertain complete remission. The progression-free survival and overall survival of this patient were 10 and 15 months, respectively. When compared with the median survival of 9 months reported in the literature, the adverse effect of CD20 negativity on prognosis may not apply to PAL patients with an occasional aberrant phenotype. Copyright © 2005 S. Karger AG, Basel
Author Contacts
Hisataka Moriwaki, MD First Department of Internal Medicine, Gifu University School of Medicine 1-1, Yanagido, Gifu 501-1194 (Japan) Tel. +81 58 230 6308, Fax +81 58 230 6310 E-Mail hmori@cc.gifu-u.ac.jp
Article Information
Received: April 22, 2004
Accepted: May 26, 2004
Number of Print Pages : 2
Number of Figures : 0, Number of Tables : 0, Number of References : 8 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|